Lisata Therapeutics Announces New Method of Use Patent Granted for Certepetide in the Treatment of Pancreatic Cancer and Other Solid TumorsGlobeNewsWire • 10/08/26
Lisata subsidiary Marea treats first patient in MAR002 acromegaly trialProactive Investors • 10/05/26
Marea Therapeutics, a Subsidiary of Lisata Therapeutics, Announces First Patient Dosed in Phase 2 Clinical Trial of MAR002, a Potential Best-in-disease Investigational Therapy for the Treatment of AcromegalyGlobeNewsWire • 10/05/26
Lisata subsidiary Marea Therapeutics gets late-breaking slot at AHA Scientific SessionsProactive Investors • 09/24/26
Marea Therapeutics, a Subsidiary of Lisata Therapeutics, Announces Upcoming Late-Breaking Presentation of MAR001 Clinical Data at the American Heart Association Scientific Sessions 2026GlobeNewsWire • 09/24/26
Lisata Therapeutics acquires Marea Therapeutics, secures $225 million private placementProactive Investors • 09/17/26
Lisata Therapeutics Announces Acquisition of Marea Therapeutics and $225 Million Concurrent Private PlacementGlobeNewsWire • 09/17/26
Lisata Therapeutics moves forward with legal action following Kuva merger terminationProactive Investors • 08/04/26
Lisata Therapeutics Provides Update Following Termination of Merger AgreementGlobeNewsWire • 08/04/26
Johnson Fistel Investigates Lisata Therapeutics, Inc. (LSTA) After Disclosures Concerning Acquisition FinancingGlobeNewsWire • 06/26/26
SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Lisata Therapeutics, Inc. (LSTA)Newsfile Corp • 06/15/26
Halper Sadeh LLC is Investigating Whether SILA and LSTA are Obtaining Fair Deals for their ShareholdersGlobeNewsWire • 05/04/26
Shareholder Alert: The Ademi Firm investigates whether Lisata Therapeutics Inc. is obtaining a Fair Price for its Public ShareholdersPRNewsWire • 03/09/26
Lisata Therapeutics Enters into Definitive Agreement to be Acquired by Kuva Labs, Inc.GlobeNewsWire • 03/06/26
Lisata Therapeutics Announces Mutual Termination of License Agreement with Qilu Pharmaceutical for CertepetideGlobeNewsWire • 01/27/26
LSTA Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Lisata Therapeutics, Inc. is Fair to ShareholdersBusiness Wire • 01/21/26
Lisata Therapeutics to be acquired by Kuva Labs in $4-per-share cash dealProactive Investors • 01/21/26